Published Date: 26 Apr 2023
According to recent studies, the prevalence of HIV is 2.5 times higher in South London's mental health service users than it is in the general population. The article was released today in BMJ Open.
Read Full NewsFrontlines with Frontera, a podcast hosted by neurointensivist Jennifer Frontera, MD, brings you an exclusive interview with Sahar Zafar, MD, MBBS. [LISTEN TIME: 30 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 19, 2025.
GLP-1 research in neurology is on the rise, with several pivotal studies lending insights into their role.
Fear of Movement, Central Sensitization May Worsen Outcomes in Gout
FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026
FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease
Weight-Loss Interventions Improve Psoriasis Severity, Quality of Life
1.
Are ultramarathon runners really at increased risk of bowel cancer?
2.
Cancer After Weight Loss; How Older Adults Use the Healthcare System.
3.
ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?
4.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
5.
No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.
1.
Florinef: Understanding Its Uses and Side Effects
2.
Discovering the Benefits of TNK: A Comprehensive Blog Article
3.
How AI is Transforming Diagnostics, Drug Discovery, and Personalized Oncology
4.
Understanding QSOFA: A Vital Tool for Recognizing Sepsis
5.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation